Update on Immunosuppression in Liver Transplantation

The standard therapy for decompensated end-stage chronic liver disease of any etiology and acute fulminant hepatic failure is liver transplantation (LT). Advances in immunosuppressive therapy decreased the rates of acute and chronic rejections. Thus, graft and patient survivals have significantly im...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasdogan, Burcak E, Ma, Michelle, Simsek, Cem, Saberi, Behnam, Gurakar, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047305/
https://www.ncbi.nlm.nih.gov/pubmed/32117698
http://dx.doi.org/10.5005/jp-journals-10018-1301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047305/
https://www.ncbi.nlm.nih.gov/pubmed/32117698
http://dx.doi.org/10.5005/jp-journals-10018-1301

Ejemplares similares